Naoto T Ueno, MD, PhD@teamoncology
How KVM can dramatically improve your remote work setup. https://jmbusinesssecurity.co.uk/2020/03/28/blogs20200328a/amp/…
posted at 22:56:38
| Stats | Twitter歴 4,249日（2009/04/14より） |
ツイート数 70,291（16.5件/日） |
表示するツイート :
2020年11月29日(日)1 tweetsource
2020年11月22日(日)3 tweetssource
Naoto T Ueno, MD, PhD@teamoncology
Two sons. https://www.instagram.com/p/CH5JQajBB5_/?igshid=i9i62z9dp2rz…
posted at 21:22:51
Naoto T Ueno, MD, PhD@teamoncology
My sons. https://www.instagram.com/p/CH5Ifz-BAkv/?igshid=1bc8chpps4ncx…
posted at 21:16:13
Naoto T Ueno, MD, PhD@teamoncology
.@JTOP_workshop hosted a 9-hour workshop to provide the concept of team science to improve cancer multidisciplinary care. Attended by five different countries. It was an amazing experience! Congrats to all the mentors and participants! https://pic.twitter.com/X6FAiiFHiB
posted at 20:52:51
2020年11月17日(火)1 tweetsource
Naoto T Ueno, MD, PhD@teamoncology
Hiker Rescued From Mount Rainier Makes ‘Miraculous’ Recovery. So true, "Everything in medicine has complications because we try to do these advanced things and defy death, and it’s really cool when it all works." Same thing for Oncology. https://www.nytimes.com/2020/11/15/us/mount-rainier-hiker-rescue.html?smid=tw-share…
posted at 01:08:48
2020年11月14日(土)3 tweetssource
Naoto T Ueno, MD, PhD@teamoncology
The other thing that I do not know is what to do with the use of paclitaxel as a choice to combine with immunotherapy. Positive effect in KEYNOTE-355 but IMpaassion 131 was negative. Is this just a disease demographic issue or is this a steroid effect? #bcsm #OncoAlert
posted at 06:45:23
Naoto T Ueno, MD, PhD@teamoncology
Pembrolizumab approval gives an interesting headache. Which PDL1 testing do I order for mTNBC, 22C3, or SP142? Or both. Also, if the results are discordant what do you do? For time being, it sounds like, I should test both? Or am I wrong? #bcsm #Oncoalert
posted at 06:42:54
Naoto T Ueno, MD, PhD@teamoncology
FDA Approves Pembrolizumab/Chemo for Locally Recurrent Unresectable or Metastatic TNBC. 2nd Immunotherapy was approved. This approval gives more choice of chemo to combine with immunotherapy. #bcsm #OncoAlert https://www.onclive.com/view/fda-approves-pembrolizumab-chemo-for-locally-recurrent-unresectable-or-metastatic-tnbc… via @onclive
posted at 06:39:14
2020年11月13日(金)2 tweetssource
Naoto T Ueno, MD, PhD@teamoncology
Learn about inflammatory breast cancer at Virtual Educational Session on 12/5. It is free. https://www.mdanderson.org/education-training/professional-education/cme-conference-management/conferences/international-inflammatory-breast-cancer-.html…
posted at 23:35:11
Naoto T Ueno, MD, PhD@teamoncology
Trend in Texas. Very concerning. https://pic.twitter.com/gktWGZJbwJ
posted at 23:31:58
2020年11月09日(月)1 tweetsource
Naoto T Ueno, MD, PhD@teamoncology
Alex Trebek, longtime "Jeopardy!" host, dies at 80. We will miss him very much. I start watching his show at US Naval Hospital cafeteria everyday when I was an intern. https://youtu.be/5BmstMhYBhs
posted at 10:53:14
2020年11月08日(日)1 tweetsource
Naoto T Ueno, MD, PhD@teamoncology
.@InflammatoryBCa @mdMD @BootWalk would like to thank you for the donation of more than 45K for inflammatory breast cancer research. We had a virtual Boot Walk this morning !! It went very well. #endcancer https://pic.twitter.com/yeCZq3aszg
posted at 00:59:28
2020年11月07日(土)1 tweetsource
Naoto T Ueno, MD, PhD@teamoncology
We welcome Dr. @DrGEcheverria from @bcmhouston to the @InflammatoryBCa research meeting. She talked about the mitochondrial network changes in TNBC after chemotherapy can be potentially targetable and predictive to the outcome. #OncoAlert #bcsm
https://www.bcm.edu/research/labs-and-centers/faculty-labs/gloria-echeverria-lab… https://pic.twitter.com/ZzopMSM8xV
posted at 03:52:01
2020年11月06日(金)1 tweetsource
Naoto T Ueno, MD, PhD@teamoncology
Please join the virtual education session for the management of inflammatory breast cancer, patients, caregiver, and healthcare providers to join this free event on coming Dec 5. Register now. #bcsm #Oncoalert
https://www.mdanderson.org/education-training/professional-education/cme-conference-management/conferences/international-inflammatory-breast-cancer-.html…
posted at 05:42:55
2020年10月31日(土)1 tweetsource
Naoto T Ueno, MD, PhD@teamoncology
【IBC International Conference - Virtual Education Day, Dec 5 2020】
Registration is now open and free of charge to anybody who is interested in inflammatory breast cancer.
Open for patients & healthcare providers. CME credited.
#OncoAlert #bcsm
https://www.mdanderson.org/education-training/professional-education/cme-conference-management/conferences/international-inflammatory-breast-cancer-.html#.X5xqXbMmCfk.twitter…
posted at 04:36:44
2020年10月26日(月)3 tweetssource
Naoto T Ueno, MD, PhD@teamoncology
IBC Learning Academy by @TalkIBC. @MDAndersonNews @ibcIBC would like to see more IBC patient and research advocate not just for MD Anderson but for other locations like @4dukeibc @IBC_DanaFarber @IBC_Consortium etc. The more advocates that we have, it will bring Hope. #OncoAlert
posted at 04:21:51
Naoto T Ueno, MD, PhD@teamoncology
Happy that @InflammatoryBCa Research Program and Clinic can contribute to the Learning Academy. Our goal is to increase the number of IBC Patient & Research Advocates so that we can have a more robust IBC community for the USA and the world. #OncoAlert https://twitter.com/TalkIBC/status/1320173215394783233…
posted at 04:18:13
Naoto T Ueno, MD, PhD@teamoncology
The world's first success in Avatar Robotic Healthcare workshop success by @JTOP_workshop and @MDAndersonNews. Noted by Asahi Newspaper. https://webronza.asahi.com/science/articles/2020102200003.html…
posted at 04:15:49
2020年10月23日(金)1 tweetsource
Naoto T Ueno, MD, PhD@teamoncology
@InflammatoryBCa researchers from @MDAndersonNews developing a new treatment for triple-negative inflammatory breast cancer. #endcancer #bcsm #OncoAlert http://www.khou.com/article/news/health/inflammatory-breast-cancer-breakthrough-ibc-md-anderson-research/285-1eb66497-47b6-4150-bef4-ff6d081f8d39… via @KHOU
posted at 00:09:06
2020年10月17日(土)4 tweetssource
Naoto T Ueno, MD, PhD@teamoncology
We thank you very much for highlighting the most aggressive form of breast cancer, inflammatory breast cancer, IBC. @MDAndersonNews is here to help patients with our best treatment and research. #endcancer #bcsm #oncoalert https://twitter.com/ShernMinKHOU/status/1317173615536836611…
posted at 05:32:47
Naoto T Ueno, MD, PhD@teamoncology
@ShernMinKHOU @InflammatoryBCa @MDAndersonNews We thank you very much for the opportunity to highlight inflammatory breast cancer. Our passion is to help patients with our best care and research @MDAndersonNews
posted at 05:30:53
Naoto T Ueno, MD, PhD@teamoncology
New hope for patients with Inflammatory breast cancer. Targeting EGFR in triple-negative receptor IBC. Research does make a difference. Research supported by @NIHFunding @BCRFcure and @InflammatoryBCa at MD Anderson https://youtu.be/H0pJINX4TD4 #bcsm #OncoAlert #endcancer
posted at 03:01:33
Naoto T Ueno, MD, PhD@teamoncology
I thank you for @BCRFcure Estee Lauder Award supporting the inflammatory breast cancer research, which helps me to be creative and taking more risks to make a difference for patients with IBC. I am committed to improving the survival of IBC. #oncoalert https://pic.twitter.com/SbODEiCMtr
posted at 01:46:55
2020年10月16日(金)6 tweetssource
Naoto T Ueno, MD, PhD@teamoncology
First breakout session of ILC and IBC at @BCRFcure retreat. It was great to learn from a fabulous collection of investigators. Opportunities to collaborate and share resources. #bcsm #oncoalert
posted at 04:49:48
Naoto T Ueno, MD, PhD@teamoncology
It was a great pleasure to visit @ibcIBC virtually. @InflammatoryBCa found two areas to collaborate. Thank you !! #oncoalert #bcsm https://twitter.com/IBC_DanaFarber/status/1316778251688255489…
posted at 04:43:43
Naoto T Ueno, MD, PhD@teamoncology
A great lecture. Showing the HIF gene-enrichment in TNBC. Potential for bringing kidney cancer drug to TNBC. Dr. Kaelin's quote "simple hypothesis" is what I like. Complex biology dissected by simple hypothesis, wow. Of course, he is a Nobel laureate.
#oncoalert https://twitter.com/BCRFcure/status/1316824674731544576…
posted at 04:41:56
Naoto T Ueno, MD, PhD@teamoncology
@IBC_DanaFarber I appreciate the opportunity!
posted at 04:34:12
Naoto T Ueno, MD, PhD@teamoncology
Very nice work from @sofiamerajver. Yes, we are making the progress but it still has not reached the level of outcome that we see for the regular breast cancer. Also, we need to help more black patients with inflammatory breast cancer. #bcsm #oncoalert https://twitter.com/UMich/status/1316499019934371840…
posted at 00:19:37
Naoto T Ueno, MD, PhD@teamoncology
Attending @BCRFcure retreat. Dr. Larry Norton emphasizes the importance of creativity in breast cancer research. BCRF funds "people." A very nice quote. #OncoAlert #bcsm
posted at 00:15:38
2020年10月13日(火)1 tweetsource
Naoto T Ueno, MD, PhD@teamoncology
The world's 1st fusion of the real & virtual world by @ana_avatar_in & @JTOP_workshop. Watch the video on how the world has changed. The oncology workforce gets together in Tokyo from MD Anderson, Taiwan, Korea, Philippines without traveling. https://youtu.be/7mvUyA7bATI #OncoAlert
posted at 01:29:22
2020年10月11日(日)3 tweetssource
Naoto T Ueno, MD, PhD@teamoncology
The world's 1st successful workshop by MICE Avatar x Team Science by @ana_avatar_in and @JTOP_workshop. @MDAndersonNews staff teleported to Tokyo. The fusion of the real and the virtual world. This is the future. #OncoAlert #bcsm https://youtu.be/7mvUyA7bATI
posted at 23:58:25
Naoto T Ueno, MD, PhD@teamoncology
Very successful Team Science Workshop x Avatar MICE by
@ANA_avatar_in and @JTOP_workshop. Video Part II. https://pic.twitter.com/ee5ennNi7Q
posted at 21:27:27
Naoto T Ueno, MD, PhD@teamoncology
Team Science Workshop x Avatar MICE by
@ANA_avatar_in and @JTOP_workshop. The robotic avatar-based world's 1st workshop for oncology healthcare providers in Tokyo. https://pic.twitter.com/iU1CY0LQ7z
posted at 21:25:18
2020年10月09日(金)1 tweetsource
Naoto T Ueno, MD, PhD@teamoncology
Team Science Workshop x Avatar MICE by @ANA_avatar_in. The robotic avatar-based world's 1st workshop for oncology healthcare providers in Tokyo. We will teleport @MDAndersonNews staff, from Philippine, Taiwan, and Korea. "Beam me up, Scotty." #OncoAlert
https://prtimes.jp/main/html/rd/p/000000003.000057512.html… https://pic.twitter.com/dSHidhmek7
posted at 21:48:29
2020年10月08日(木)1 tweetsource
Naoto T Ueno, MD, PhD@teamoncology
We are now having a social get-together for patients & caregivers with inflammatory breast cancer. Please join now. We will go for another one hour. 8:30 pm CST. #bcsm https://mdacc.zoom.us/j/95517354703?pwd=SXNqOHdlRnBSeTRKSU82R2luVVdUZz09#success…
posted at 09:39:00
2020年10月06日(火)3 tweetssource
Naoto T Ueno, MD, PhD@teamoncology
A great meeting to attend on Oct 30th to learn about the latest in liquid biopsy. The registration is free. Dr. @MCristofanill leading the effort. #OncoAlert #bcsm https://www.islbcongress2020.org/
posted at 03:29:53
Naoto T Ueno, MD, PhD@teamoncology
.@MDAndersonNews faculty and staff will teleport to Tokyo so that they can conduct an oncology educational workshop. We will use a robotic Avatar to teleport ourselves working with #Avtarin. The world's first attempt. #endcancer
https://twitter.com/nuenojpn/status/1313088498765901827… https://pic.twitter.com/vCpUhcNAaU
posted at 00:26:01
Naoto T Ueno, MD, PhD@teamoncology
I have now reached 4600 dollars. We will match your donation dollar by dollar. I need to reach 10K, please help @InflammatoryBCa. MD Please help inflammatory breast cancer research. Every dollar counts. @BootWalk
https://secure3.convio.net/mdacc/site/TR/Walk/BootWalk?px=1002116&pg=personal&fr_id=1341… https://pic.twitter.com/bgcXlb6BSD
posted at 00:21:53
2020年10月05日(月)1 tweetsource
Naoto T Ueno, MD, PhD@teamoncology
A beautiful day to kickoff the @BootWalk for the team IBC Wrangler, @InflammatoryBCa. From today, if you donate now for IBC research, Terry Arnold, @ibcnetwork_ will match your donation. Please donate. https://secure3.convio.net/mdacc/site/TR/Walk/BootWalk?px=1002116&pg=personal&fr_id=1341… #oncoalert #bcsm https://pic.twitter.com/x0ewHHkGOS
posted at 06:45:19
2020年10月02日(金)3 tweetssource
Naoto T Ueno, MD, PhD@teamoncology
I appreciate @IBC_DanaFarber @DanaFarber for inviting me to the Susan E. Donelan Lectureship. After the talk, I met many wonderful investigators which will lead to collaborations between DFCI and @MDAndersonNews, and @InflammatoryBCa. #bcsm #Oncoalert https://twitter.com/antgiorda/status/1311481571019546624…
posted at 22:07:08
Naoto T Ueno, MD, PhD@teamoncology
@antgiorda @InflammatoryBCa @IBC_DanaFarber @IBCResearch @IBC_Consortium Thank you, Antonio, for your kind words.
posted at 22:02:58
Naoto T Ueno, MD, PhD@teamoncology
A great resource for patients with inflammatory breast cancer and their caregivers. Written by many well known IBC investigators and patient advocates. Highly recommended. #bcsm #endcancer
https://smile.amazon.com/Overcoming-Inflammatory-Breast-Cancer-Levine/dp/1735772909/ref=sr_1_1?dchild=1&keywords=overcoming+inflammatory+breast+cancer&qid=1601488107&sr=8-1…
posted at 22:02:10
2020年09月29日(火)1 tweetsource
Naoto T Ueno, MD, PhD@teamoncology
Great teamwork by @jleePSOC @pkuhn1
@nievamd @MDAndersonNews @uscmichelsoncsi
@USCViterbi @KeckMedUSC. Wearable Activity Trackers in Patients With Cancer Undergoing Chemo: Toward Evaluating Risk of Unplanned Health Care Encounters. https://ascopubs.org/doi/full/10.1200/CCI.20.00023#.X3IZdkxV0aU.twitter… #bcsm #oncoalert
posted at 02:16:00
2020年09月26日(土)1 tweetsource
Naoto T Ueno, MD, PhD@teamoncology
がん医療に携わる医療従事者が、チームとなって行うべきがん医療、地域連携について、参加型セミナーを通じて、全員が理解を深め、実践できるようになるための知識とスキルを身につける日本語で実施されるオンラインワークショップが2020年11月15日に開催。参加者募集中
https://www.teamoncology.com/seminar/seminar/2020_05_seminar/top…
posted at 22:25:17
2020年09月25日(金)1 tweetsource
Naoto T Ueno, MD, PhD@teamoncology
Please help me to raise 10K for inflammatory breast cancer (IBC) research, now 3.7 K. Patients with IBC is facing a life and death situation. We need better treatment. Your every dollar will make a big difference. https://secure3.convio.net/mdacc/site/TR/Walk/BootWalk?px=1002116&pg=personal&fr_id=1341&fbclid=IwAR0FvpO2s28YSAni67Er0zow-OL3-uTBgBrLuLj03BDa_SprVaFn_w5fvOc…
posted at 04:21:28
2020年09月24日(木)1 tweetsource
Naoto T Ueno, MD, PhD@teamoncology
MD Anderson, non-inflammatory breast cancer algorithm updated. →
https://www.mdanderson.org/content/dam/mdanderson/documents/for-physicians/algorithms/cancer-treatment/ca-treatment-breast-invasive-web-algorithm.pdf…
For inflammatory breast cancer treatment algorithm → https://www.mdanderson.org/content/dam/mdanderson/documents/for-physicians/algorithms/cancer-treatment/ca-%20treatment-breast-inflammatory-web-algorithm.pdf…
The treatment algorithm is open access to anyone. #bcsm #OncAlert
posted at 09:31:03
2020年09月20日(日)10 tweetssource
Naoto T Ueno, MD, PhD@teamoncology
@kgapo Robotic Avatar. We plan to have an educational workshop by connecting the USA, Taiwan, and Japan.
https://www.youtube.com/watch?v=1cf0fcDp4qo…
posted at 22:53:25
Naoto T Ueno, MD, PhD@teamoncology
@kgapo I would love to. Here are some of the items that we are testing with my colleague. https://www.youtube.com/watch?v=TPdaM-ZTToE…
posted at 22:52:27
Naoto T Ueno, MD, PhD@teamoncology
If we can teleport people by robotic avatar and VR world, we can democratize medical knowledge and reduce unnecessary travel in medical travel. Need to think differently to bring a paradigm shift. #OncoAlert
posted at 22:50:08
Naoto T Ueno, MD, PhD@teamoncology
Robotic Avatar & VR world are something that I am testing to bring as the next gen tool and for conferences. Only 9% of the world population can fly before COVID-19 pandemic. We need to bring closer by moving human to other locations for real interaction. This is not SF anymore.
posted at 22:48:27
Naoto T Ueno, MD, PhD@teamoncology
The conference content is real stuff but there is a next-generation conference platform, which is "virtual" by using a VR & Avatar. The "virtual" means not the content but bringing in human to human interaction settings in a virtual world. Time to evolve beyond Zoom. #Oncoalert https://twitter.com/FAndreMD/status/1307602700331347968…
posted at 22:44:58
Naoto T Ueno, MD, PhD@teamoncology
Same trend as KEYNOTE-522 (pembrolizumab). We now have two studies that showed improvement of pCR by immune checkpoint blockade and chemotherapy. And one negative. We will see if FDA will approve these drugs. #ESMO2020 #oncoalert #bcsm https://twitter.com/BCancerAcademy/status/1307632315833647104…
posted at 21:23:19
Naoto T Ueno, MD, PhD@teamoncology
It is interesting to see Abemaciclib to see that the proliferation reduced but there are not unique gene getting upregulated. #bcsm #Oncoalert #esmo20 https://twitter.com/matteolambe/status/1307649026024767488…
posted at 21:15:08
Naoto T Ueno, MD, PhD@teamoncology
OS tending to improve but still not statistically significant. The best benefit may be with live and lung met. The study is underpowered. #OncoAlert #BCSM #ESMO20 https://twitter.com/prat_aleix/status/1307341573764636672…
posted at 05:12:40
Naoto T Ueno, MD, PhD@teamoncology
No difference in PFS or OS, IMpaassion 131. You can not use paclitaxel combined with atezolizumab. #bcsm #ESMO20 #OncoAlert https://twitter.com/jesusanampa/status/1307327391614865408…
posted at 04:59:30
Naoto T Ueno, MD, PhD@teamoncology
OS benefit of Sacituzumab. We and FDA are happy to confirm the OS benefit of sacituzumab in advanced TNBC. #bcsm #ESMO20 #OncoAlert https://twitter.com/GaiaGriguolo/status/1307338148184236033…
posted at 04:57:42
